Jeffrey A. Lieberman, M.D.

Original Research

Comparison of Quetiapine and Risperidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Flexible-Dose, 8-Week Study

July 14, 2006

Academic Highlights

Preventing Clinical Deterioration in the Course of Schizophrenia: The Potential for Neuroprotection.

June 15, 2006

Original Research

Olanzapine Versus Risperidone in Newly Admitted Acutely Ill Psychotic Patients

December 15, 2005

Original Research

Effects of Atypical Antipsychotics on the Syndromal Profile in Treatment-Resistant Schizophrenia

April 1, 2004

Original Research

Prolactin Levels in Schizophrenia and Schizoaffective Disorder Patients Treated With Clozapine, Olanzapine, Risperidone, or Haloperidol

January 1, 2004

Article

Introduction. Quetiapine: A 5-Year Update

December 31, 2002

Original Research

Olanzapine in Refractory Schizophrenia After Failure of Typical or Atypical Antipsychotic Treatment: An Open-Label Switch Study

October 1, 2002

Article

Hypothesis and Hypothesis Testing in the Clinical Trial

August 1, 2001

Article

Genetic Dissection of Atypical Antipsychotic-Induced Weight Gain: Novel Preliminary Data on the Pharmacogenetic Puzzle

January 9, 2001

Article

Pathophysiologic Mechanisms in the Pathogenesis and Clinical Course of Schizophrenia

December 1, 1999

Article

Maximizing Clozapine Therapy: Managing Side Effects

July 1, 1998

Original Research

The Prevalence of Acute Extrapyramidal Signs and Symptoms in Patients Treated With Clozapine, Risperidone, and Conventional Antipsychotics

February 15, 1998